Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.42 |
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.38 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.38 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.38 |
| ▸ | FURIN | P09958 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | LSS | P48449 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20783443 | 0.94 | GAA (0.43) | L3MBTL1GAAFURINKMT2APKM | |
| SCHEMBL22639048 | 0.94 | GAA (0.43) | L3MBTL1GAAFURINKMT2APKM | |
| SCHEMBL10075727 | 0.94 | GAA (0.43) | L3MBTL1GAAFURINKMT2APKM | |
| SCHEMBL10075733 | 0.89 | L3MBTL1 (0.39) | L3MBTL1GAAKMT2APKMLMNA | |
| SCHEMBL10075799 | 0.88 | L3MBTL1 (0.36) | L3MBTL1GAAHDAC3HDAC4HDAC1 | |
| SCHEMBL21870374 | 0.88 | L3MBTL1 (0.39) | L3MBTL1GAAFURINKMT2APKM | |
| SCHEMBL10075826 | 0.88 | L3MBTL1 (0.39) | L3MBTL1GAAFURINKMT2APKM | |
| SCHEMBL10075801 | 0.88 | L3MBTL1 (0.35) | L3MBTL1GAAKMT2APKMLMNA | |
| SCHEMBL10075824 | 0.87 | L3MBTL1 (0.38) | L3MBTL1GAAFURINKMT2APKM | |
| SCHEMBL10075820 | 0.86 | L3MBTL1 (0.39) | L3MBTL1GAAFURINKMT2APKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2586827-B1 | CURABLE RESIN COMPOSITION | ADEKA CORP (JP) | 2017-12-27 | — | — | EP | disclosed |
| US-8735511-B2 | Curing resin composition | ADEKA CORPORATION (JP) | 2014-05-27 | — | — | US | disclosed |
| US-8735511-B2 | Curing resin composition | ADEKA CORPORATION (JP) | 2014-05-27 | — | — | US | disclosed |
| EP-2586827-A1 | CURABLE RESIN COMPOSITION | Adeka Corporation (JP) | 2013-05-01 | — | — | EP | disclosed |
| US-20120115972-A1 | CURING RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2012-05-10 | — | — | US | disclosed |
| US-20120115972-A1 | CURING RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2012-05-10 | — | — | US | disclosed |
| US-8148045-B2 | Oxime ester compound and photopolymerization initiator containing the same | ADEKA CORPORATION (JP) | 2012-04-03 | — | — | US | disclosed |
| US-8148045-B2 | Oxime ester compound and photopolymerization initiator containing the same | ADEKA CORPORATION (JP) | 2012-04-03 | — | — | US | disclosed |
| EP-2327689-B1 | Oxime ester compound and photopolymerization initiator containing the same | ADEKA CORP (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-20110129778-A1 | OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME | ADEKA CORPORATION (JP) | 2011-06-02 | — | — | US | disclosed |
| US-20110129778-A1 | OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME | ADEKA CORPORATION (JP) | 2011-06-02 | — | — | US | disclosed |
| EP-2327689-A1 | Oxime ester compound and photopolymerization initiator containing the same | Adeka Corporation (JP) | 2011-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110129778-A1 | OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME | OXER1, OR10J3, CDK11B | L3MBTL1 1628/4885GAA 4794/4885HDAC3 2219/4885 |
| US-20120115972-A1 | CURING RESIN COMPOSITION | LTA, LOXL1, PLOD2 | L3MBTL1 228/4885GAA 3567/4885HDAC3 3483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.